Florent Creusat

Florent Creusat

Auto-generated profile, based on publicly available information

Florent Creusat

INSERM, Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2024 in Science Advances
Verified
Journal Article
Open access
FCFlorent Creusat
Florent Creusat
YJYouenn Jouan
Youenn Jouan
LGLoïc Gonzalez
Loïc Gonzalez
EBEmilie Barsac
Emilie Barsac
GIGuy Ilango
Guy Ilango
CPChristophe Paget
Christophe Paget
Neutrophil subsets endowed with regulatory/suppressive properties are widely regarded as deleterious immune cells that can jeopardize antitumoral response and/or antimicrobial resistance. Here, we describe a sizeable fraction of neutrophils characterized by the expression of programmed death-ligand 1 (PD-L1) in biological fluids of humans and mice with severe viral respiratory infections (VRI). Biological and transcriptomic approaches indicated that VRI-driven PD-L1 + neutrophils are endowed with potent regulatory functions and reduced classical antimicrobial properties, as compared to their PD-L1 − counterpart. VRI-induced regulatory PD-L1 + neutrophils were generated remotely in the bone marrow in an IFN-γ–dependent manner and were quickly mobilized into the inflamed lungs where they fulfilled their maturation. Neutrophil depletion and PD-L1 blockade during experimental VRI resulted in higher mortality, increased local inflammation, and reduced expression of resolving factors. These findings suggest that PD-L1 + neutrophils are important players in disease tolerance by mitigating local inflammation during severe VRI and that they may constitute relevant targets for future immune interventions.